Results
1 -
10 of
36
(Click
here to explore results)
- A low-cost voltammetric sensor based on multi-walled carbon nanotubes for highly sensitive and accurate determination of nanomolar levels of the anticancer drug Ribociclib in bulk and biological fluids. Wiem Bouali, Nevin Erk, Asena Ayse Genc
, Anal. Methods
, 2024
, 16
, 1623
- CDK4/6 inhibitors: a brief overview and prospective research directions. Tenzin Adon, Dhivya Shanmugarajan, Honnavalli Yogish Kumar
, RSC Adv.
, 2021
, 11
, 29227
- Solubility and permeability enhancement of BCS class IV drug ribociclib through cocrystallization. M. K. Chaitanya Mannava, Abhijit Garai, Manish K. Bommaka, K. Anand Solomon, Ashwini K. Nangia
, CrystEngComm
, 2022
, 24
, 7915
- PROTACs suppression of CDK4/6, crucial kinases for cell cycle regulation in cancer. Bosheng Zhao, Kevin Burgess
, Chem. Commun.
, 2019
, 55
, 2704
- Medicines for millions of patients. David C. Rees
, RSC Med. Chem.
, 2022
, 13
, 7
- Palladium catalyzed C–C and C–N bond forming reactions: an update on the synthesis of pharmaceuticals from 2015–2020. Jayachandra Rayadurgam, Sravani Sana, M. Sasikumar, Qiong Gu
, Org. Chem. Front.
, 2021
, 8
, 384
- Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling. Thamer A. Alsubi, Mohamed W. Attwa, Ahmed H. Bakheit, Hany W. Darwish, Hatem A. Abuelizz, Adnan A. Kadi
, RSC Adv.
, 2020
, 10
, 23930
- Progress on cocrystallization of poorly soluble NME's in the last decade. Parag Roy, Animesh Ghosh
, CrystEngComm
, 2020
, 22
, 6958
- In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling. Thamer A. Alsubi, Mohamed W. Attwa, Ahmed H. Bakheit, Hany W. Darwish, Hatem A. Abuelizz, Adnan A. Kadi
, RSC Adv.
, 2020
, 10
, 22668
- Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation. Sarah A. Ghobish, Khaled O. Mohamed, Nahla Farag, Doaa B. Farag
, RSC Med. Chem.
, 2024
, 15
, 293